Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical device ...
X4 Pharmaceuticals Announces Strategic Restructuring to Drive Value and Maximize ...
Full enrollment in ongoing global, pivotal Phase 3 clinical trial in chronic neutropeniaon track for mid-2025 Right-sizing commercial efforts to optimize XOLREMDI promotion and support U.S. WHIM syndr ...
Retail Insider7 小时
Front-of-package food labels: A path to healthier choices
New front-of-package food labels will be mandatory in Canada by 2026, aiming to guide healthier choices with clear, visible ...